Clinical data analysis revealed a strong correlation between high levels of PBX2, PRMT1, SMARCC1, and IGF2BP2 with poor prognosis and tumor progression in HNSCC patients. This evidence concerns the gene PRMT1 and head and neck squamous cell carcinoma.